Skip to Main Content

Paper Details

SARS-CoV-2 infection triggers pro-atherogenic inflammatory responses in human coronary vessels.
Nat Cardiovasc Res
12
2023
COVID-19, Patients, SARS, SARS-, SARS-CoV-2, SARS-CoV-2 viral RNA, arterial lesions, atherosclerotic, atherosclerotic plaques, cardiovascular complications, cholesterol, coronary lesions, coronavirus disease 2019, cultured macrophages, human, ischemic cardiovascular complications, macrophage, neuropilin-1, plaque inflammation, plaque macrophages, primary macrophages, severe acute respiratory syndrome coronavirus 2
Author NameAffiliation
Natalia EberhardtNYU Cardiovascular Research Center, New York University School of Medicine
Letizia AmadoriNYU Cardiovascular Research Center, New York University School of Medicine
Michael SchotsaertIcahn School of Medicine at Mount Sinai, USA Global Health and Emerging Pathogens Institute
Chiara GiannarelliNYU Cardiovascular Research Center, New York University School of Medicine
Chiara GiannarelliPrecision Immunology Institute, Icahn School of Medicine at Mount Sinai
Chiara GiannarelliNew York University School of Medicine
  • 1 - 6

Datasets

Release 1.2